Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid

BACKGROUND: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. Biomarkers that can help monitor the progression of PD or response to disease-modifying agents will be invaluable in making appropriate therapeutic decisions. Further, biomarkers that could be used to disti...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Chan Hyun, Sathe, Gajanan, Rosenthal, Liana S., Moghekar, Abhay R., Dawson, Valina L., Dawson, Ted M., Pandey, Akhilesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197159/
https://www.ncbi.nlm.nih.gov/pubmed/32390785
http://dx.doi.org/10.1186/s12014-020-09277-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197159/
https://www.ncbi.nlm.nih.gov/pubmed/32390785
http://dx.doi.org/10.1186/s12014-020-09277-8

Ejemplares similares